The move might at first sound like little more than a reduced hassle—and maybe reckless, since there was good evidence in ...
HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...
Deep in the folds of the intestine, in microscopic pockets called crypts, a quiet surveillance system is always at work. Stem ...
Johnson & Johnson (NYSE:JNJ) today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in ...
Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...
Marked underrepresentation of non-White patients persists in ovarian cancer trials, and incomplete race/ethnicity reporting undermines external validity and equity-focused interpretation of outcomes.
Postpartum breast cancer is diagnosed five to ten years after giving birth. It is associated with a higher risk of metastasis and a lower survival rate compared with women who have not been pregnant ...
Although progression-free survival was similar across racial groups, overall survival was shorter for Black patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results